Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy
暂无分享,去创建一个
F. Bidard | J. Pierga | P. Cottu | E. Brain | M. Tanguy | M. Rodrigues | F. Lerebours | M. Bergqvist | L. Cabel | Nicolas Kiavue | D. Loirat | A. Donnadieu | D. Rosenblum | A. Béthune